Newsroom

News

The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is growing: In the past three years, the institute – a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University (UdS) – has appointed five professors together with the UdS. To further strengthen the focus on active ingredients at the Saarbrücken campus, the university has filled two additional professorships in this field. To ensure that the researchers have adequate laboratory and office space, several construction projects are planned that will provide space for 330 researchers by 2029. The structural expansion is financed by federal and state development funds totaling 55.7 million euros.

29.10.2024

HIPS

News

Our immune system successfully defends itself against pathogens on a daily basis - often without us realizing it. We notice other encounters with pathogens through cold symptoms, fever or a red, swollen area. Our immune system is then working at full speed. Prof. Kathrin de la Rosa wants to be one step ahead of the pathogens. Since 2024, she has headed the department “Personalized Immunotherapy” at the Centre for Individualized Infection Medicine (CiiM) - a joint institution of Hannover Medical School and the HZI. In the HZI podcast InFact, she reports on how she wants to improve individual defense mechanisms in people whose immune system cannot cope with the pathogen on its own and explains why she is copying tricks from nature.

28.10.2024

CiiM

Angela Ittel, Josef Penninger, Frank Eggert

News

Prof. Josef Penninger, Scientific Director of the Helmholtz Centre for Infection Research (HZI) in Braunschweig, has been appointed honorary professor of the Faculty of Life Sciences at Technische Universität Braunschweig. The faculty honors his outstanding achievements in cell and molecular biology research, including the cloning of the SARS-CoV-2 receptor, and his outstanding ability to network scientific institutions.

22.10.2024

HZI Campus

News

Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent of treated patients. A research team at the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) has now been able to produce an inactivated, harmless form of colistin that is only activated in the body with the help of chemical switches. In this so-called click-to-release technique, the chemical switches are specifically bound to the disease-causing bacteria. The administered masked colistin is therefore activated specifically at the site of action. The researchers hope that this could reduce side effects. The study was published in the journal Angewandte Chemie.

21.10.2024

HZI Campus

News

According to the WHO, antimicrobial resistance (AMR) is one of the ten greatest threats to global health. In the EU alone, around 35,000 people die every year from antibiotic-resistant infections. The WHO estimates that 1.27 million deaths worldwide in 2019 were directly attributable to drug-resistant infections.

18.10.2024

HZI Campus

Schematic representation of metagenome data

News

Microorganisms do not just colonize the body of mammals during infections. Billions of microbes can be found on and in healthy humans and animals at any given time, communicating with each other via chemical signals and thus influencing their health. In two studies, researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and Saarland University Hospital have now conducted a detailed study of the microbiome, i.e. the totality of all microorganisms, in humans and zoo animals. The aim was to identify starting points for strategies for the treatment and diagnosis of diseases. The researchers published their results in two articles in the journal Nature Communications. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

17.10.2024

HIPS

Back to the first page
...
23
24
25
26
...
154

HZI in the media

zur Bekämpfung der Tuberkulose und des Helmholtz-Zentrums für Infektionsforschung erstellt. Zahlreiche weitere Fachgesellschaften und

24.03.2026

Deutsches Ärzteblatt

... fünf Teams durch, darunter PROTON vom Helmholtz-Zentrum für Infektionsforschung. Dieses entwickelt einen neuartigen Wirkstoff gegen ...

22.03.2026

Ad Hoc News

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026

Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026

Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.